| Z.A. Dalu M.D.
Established Expert Specialist Treatment with Confidence In a Private, Discreet Setting Confidential Counseling Testing & Treatment Next-day Results for Testing Home Page |
Big Bend-Clayton Medical Bldg 6744 Clayton RD Suite 305 St. Louis, Missouri 63117 314-647-1231 (FAX) 314-647-1297 Click here for Map |
Office Hours
Monday-Friday 12:30 pm to 5 pm No appointment necessary by walk-in only New patients are always welcomed!
|
|
Methods of Payment
|
Sponsor & Instructor in Sexually Transmitted Diseases to Internal Medicine Residents & Infectious Disease Fellows of St. Louis Iniversity School of Medicine
Sponsor and Instructor to first year medical students of Saint Louis University School of Medicine, Community Medicine Department.
Peter Leone M.D., Raymond B. Johnson M.D., and the Trovafloxacin Gonorrhea Study Group. Published in the American Journal of Medicine, Volume 104, January, 1998.
Robert B. Jones M.D., John M. Douglas Jr. M.D., H. Hunter Hansfield M.D., Edward w. Hook III M.D., Brant L. Viner M.D., Joseph W. Shands, Jr. M.D., and William M. McCormick M.D.,
Published in the American Journal of Medicine, March, 1993.
Robert B. Jones M.D., Scott J. Hopkins M.D., Raymond B. Johnson M.D., and the Azithromycin for Chlamydial Infections Study Group, Published by the New England Journal of Medicine, September, 1992.
7-11-89 through 11-1-89. Multicenter Trial of ****** And Ceftriaxone in the treatment of uncomplicated Gonorrhea Total Enrollment - 120. Hoffman LaRoche. Dr. David J. Pizzuti Study Director, Nutley, New Jersey.
10-18-89 through 1-11-90. Comparison of Oral ******and Ceftriaxone in the Treament of Uncomplicated Gonococcal Infection. Total Enrollment - 121. Upjohn.Ken Tuck M.D., Kalamazoo, Michigan
2-8-90 through -9-13-90. ****** in the treatment of Chlamydial Urethritis/ Cervicitis a Multicenter Comparative Study. Total Enrollment - 103. Pfizer Dr. R. B. Johnson, Groton, Connecticut.
8-24-90 through 1-15-92 (180 patients)
8-8-91 through 10-28-91 (60 patients)
A Multicenter Open Comparative Trial of ******* and Ceftriaxone in
Patients with Uncomplicated Gonococcal Urethritis / Cervicitis. Total Enrollment
- 240. Pfizer. R.B. Johnson, M.D., Senior Associate Director, Groton, Connecticut.
10 - 16 - 90 through 4 - 28 - 92. Randomized Multidose, Double blInd Study of ******* in Chlamydial Urethritis / Cervicitis versus Doxycycline. Total Enrollment - 387. Hoffman - LaRoche D.J. Pizzuti, M.D. Clinical Leader, Nutley, New Jersey.
11-11-91 through 4-17-92. A Randomized Controlled Trial of the Safety and Efficacy of Single dose ******* versus Single Dose Ceftriaxone Sodium in the Treament of Uncomplicated Gonococcal Cervicitis. Total Enrollment - 146. Abbott. D. McLeod, Research Triangle Park, North Carolina.
12-20-93 through 5-11-94. A Randomized, Doubleblind, Multicenter Trial Comparing 7 days of Oral Therapy with ******* or Ciprofloxacin Hydrochloride ( 500 mg. DAILY ) for the Treatment of Uncomplicated Urinary Tract InfectIons. Total Enrollment - 12. Pfizer. Salvanor Pancorbo, PharmD., Senior Associate Director, Groton, Connecticut
6-2-93 through 2-95. A two dose Regime of Ceftriaxone versus a Single dose regime of Benzathine Penicillin G for the Treatment of Patients With Primary, Secondary, or Early Latent Stage Syphilis. Total Enrollment - 22. Hoffman - LaRoche. Lenore Fleming, Ed.D, M.D., Nutley, New Jersey.
12 - 94 through 10 - 95 A Randomized Multicenter, Double blind, Double Dummy Trial Comparing ******* with that of Ofloxacin (400 mg. ) for the Treatment of Uncomplicated Gonorrhea. Total Enrollment - 71. Pfizer. Groton, Connecticut.
3-27-95 through 5-13- 96. A Randomized, Multicenter, Doubleblind, Double Dummy Comparative Study of ******* and Doxycycline for the Treatment CF Uncomplicated Chlamydial Urethritis / Cervicitis. Total Enrollment - 95. Pfizer. Groton, Connecticut.
12-18-96 through 8-13-97. An Open Label Multicenter Safely and Efficiacy Study of Topical ****** 5% Cream in the Treatment of Visible, External Genital Perianal Warts in Male - Female Patients. Total Enrollment 10. 3 M Drug Company.
1-97 through 5-98. A Randomized, Double blind, Multicenter, Phase III Studyof to single dose Regiemens of ****** and a Single dose of Oflaxocin in the Treatment of Uncomplicated Gonococcal Infections. Total Enrollment - 23. Bristol Myers Squibb.
Sub Investigator for Family Medicine Research Center at Deaconess
HospItal for the Following Studies:
1991: A Double blind Dose Ranging Study to Assess the Safety and Efficacy of Oral BRL 42810 in Patient With First Episode Genital Herpes Infection. Smith Kline Pharmaceuticals.
1992. A Comparative Trial of 256U87 and Acylovir for the Treatment of First Episode Genital Herpes Infection. Burroughs Wellcome Company (USA)
1994. A Phase III, Randomized Double blind, Placebo-controlled, Multicenter Study of the Efficacy of an HSV Vaccine Composed of Recombinant Herpes Simplex Virus Type 2 (HSV 2) subunit Antigens Combined with MF59 Adjuvant Emulsion when given to HSV 2 Seronegative Adults at High Risk for Acquisition of a STD. The Biocine Company.
1995. A Double blind Randomized, Placebo-controlled Study to Evaluate the Efficacy of Smith Kline Beecham Biologicals' Herpes Simplex Candidate Vaccine (gD2t ) with MR.. to prevent Genital Herpes Disease in Healthy Consorts of Subjects with Genital Herpes Disease. Smith Kline Beecham Biologicals.
Future Goals:
| Z.A. Dalu M.D.
Established Expert Specialist Treatment with Confidence In a Private, Discreet Setting Confidential Counseling Testing & Treatment Next-day Results for Testing Home Page |
Big Bend-Clayton Medical Bldg 6744 Clayton RD Suite 305 St. Louis, Missouri 63117 314-647-1231 (FAX) 314-647-1297 Click here for Map |
Office Hours
Monday-Friday 12:30 pm to 5 pm No appointment necessary by walk-in only New patients are always welcomed.
|
|
Methods of Payment
|